Evotec SE (ETR:EVT)
7.34
+0.13 (1.75%)
Apr 24, 2025, 5:35 PM CET
Evotec SE Revenue
In the year 2024, Evotec SE had annual revenue of 796.97M EUR with 1.99% growth. Evotec SE had revenue of 221.23M in the quarter ending December 31, 2024, with 9.89% growth.
Revenue
796.97M
Revenue Growth
+1.99%
P/S Ratio
1.61
Revenue / Employee
168.14K
Employees
4,740
Market Cap
1.28B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 796.97M | 15.54M | 1.99% |
Dec 31, 2023 | 781.43M | 29.98M | 3.99% |
Dec 31, 2022 | 751.45M | 133.41M | 21.59% |
Dec 31, 2021 | 618.03M | 117.11M | 23.38% |
Dec 31, 2020 | 500.92M | 54.49M | 12.20% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Merck KGaA | 21.16B |
Siemens Healthineers AG | 22.67B |
Fresenius SE & Co. KGaA | 21.83B |
Bayer Aktiengesellschaft | 46.61B |
Sartorius Aktiengesellschaft | 3.44B |
Fresenius Medical Care AG | 19.34B |
Carl Zeiss Meditec AG | 2.08B |
Fielmann Group AG | 2.16B |
Evotec SE News
- 16 hours ago - Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb - Wallstreet:Online
- 16 hours ago - Evotec Announces Significant Progress in Strategic Protein Degradation Collaboration with Bristol Myers Squibb - Accesswire
- 16 hours ago - Evotec & Bristol Myers Squibb: Breakthrough in Protein Degradation - Wallstreet:Online
- 16 hours ago - EQS-News: Evotec announces significant progress in strategic protein degradation collaboration with Bristol Myers Squibb - Wallstreet:Online
- 7 days ago - Evotec SE (EVO) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Evotec SE 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Evotec SE (EVO) Reports Q4 Revenue Boost, Forecasts Strong Future Growth - GuruFocus
- 7 days ago - Earnings Scheduled For April 17, 2025 - Benzinga